TNF-308A and HLA-DR3 alleles contribute independently to susceptibility to systemic lupus erythematosus
- 1 January 2000
- journal article
- research article
- Published by Wiley in Arthritis & Rheumatism
- Vol. 43 (1) , 129-134
- https://doi.org/10.1002/1529-0131(200001)43:1<129::aid-anr16>3.0.co;2-s
Abstract
To evaluate the respective contributions of tumor necrosis factor (TNF) promoter polymorphisms and HLA-DR alleles to susceptibility to systemic lupus erythematosus (SLE). TNF-238G/A and 308G/A promoter polymorphisms and HLA-DRB1 alleles were determined in 99 consecutive Caucasian SLE patients and 177 Caucasian controls. Standard and Mantel-Haenszel odds ratios were calculated to assess the magnitude of the susceptibility factors. The presence or absence of the SLE classification criteria was determined and correlated with the TNF promoter and HLA-DRB1 genotypes. The frequency of the TNF-308A/A and 308G/A genotypes was significantly higher in SLE patients (odds ratio 5.0). Conversely, TNF-238G/A and 238A/A genotypes were equally prevalent in SLE patients and controls. The HLA-DR3 specificity (DRBI*0301 allele) was significantly more prevalent in the SLE population (odds ratio 4.4). Stratification to correct for interdependence of the 2 loci confirmed the association of both TNF-308A and HLA-DR3 with SLE (Mantel-Haenszel odds ratio 3.2 and 2.4, respectively). No correlation was found between TNF promoter and HLA-DRB1 genotypes and any SLE classification criterion or disease manifestation. TNF-308A and HLA-DR3 alleles are independent susceptibility factors for SLE.Keywords
This publication has 26 references indexed in Scilit:
- Systemic lupus erythematosus in three ethnic groups: I. The effects of HLA class II, C4, and CR1 alleles, socioeconomic factors, and ethnicity at disease onsetArthritis & Rheumatism, 1998
- Molecular analysis of major histocompatibility complex allelic associations with systemic lupus erythematosus in TaiwanArthritis & Rheumatism, 1997
- TUMOUR NECROSIS FACTOR ALPHA AND ITS SOLUBLE RECEPTORS PARALLEL CLINICAL DISEASE AND AUTOIMMUNE ACTIVITY IN SYSTEMIC LUPUS ERYTHEMATOSUSRheumatology, 1995
- DNA polymorphism of HLA class II genes in systemic lupus erythematosusTissue Antigens, 1994
- HLA Antigens in Japanese Patients with Systemic Lupus ErythematosusScandinavian Journal of Rheumatology, 1994
- HLA-DQ, DR AND COMPLEMENT C4 VARIANTS IN SYSTEMIC LUPUS ERYTHEMATOSUSRheumatology, 1993
- Major histocompatibility complex haplotypes and complement C4 alleles in systemic lupus erythematosus. Results of a multicenter study.Journal of Clinical Investigation, 1992
- Distribution of HLA class II alleles among Scandinavian patients with systemic lupus erythematosus (SLE): An increased risk of SLE among non[DRB1*03,DQA1*0501,DQB1*0201] Class II homozygotes?Tissue Antigens, 1992
- Heritable major histocompatibility complex class II-associated differences in production of tumor necrosis factor alpha: relevance to genetic predisposition to systemic lupus erythematosus.Proceedings of the National Academy of Sciences, 1990
- Tumour necrosis factorBritish Medical Bulletin, 1989